Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Skin patch treatment kills common skin cancer

Skin patch treatment kills common skin cancer

Smoking increases skin cancer risk

Smoking increases skin cancer risk

Aeterna Zentaris announces perifosine Phase 1 trial on neuroblastoma

Aeterna Zentaris announces perifosine Phase 1 trial on neuroblastoma

Even small-stage oral SCC metastases impact prognosis

Even small-stage oral SCC metastases impact prognosis

Value of pathology review highlighted in node-negative breast cancer

Value of pathology review highlighted in node-negative breast cancer

Combination therapy may help defeat pancreatic cancer

Combination therapy may help defeat pancreatic cancer

HCV suppression reduces liver damage

HCV suppression reduces liver damage

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Chemotherapy improves survival for patients with SCLC and LCNEC

Chemotherapy improves survival for patients with SCLC and LCNEC

Skin cancer does not discriminate between skin colors

Skin cancer does not discriminate between skin colors

NEJM hails vismodegib as ‘the greatest advance in therapy yet seen’ for advanced BCC

NEJM hails vismodegib as ‘the greatest advance in therapy yet seen’ for advanced BCC

Promising preliminary data for axitinib in metastatic kidney cancer

Promising preliminary data for axitinib in metastatic kidney cancer

ADAM28 inhibits VWF-mediated cancer cell apoptosis and enhances lung metastases

ADAM28 inhibits VWF-mediated cancer cell apoptosis and enhances lung metastases

Piramal to present data on several molecular imaging compounds at SNM annual meeting

Piramal to present data on several molecular imaging compounds at SNM annual meeting

Positive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD

Positive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD

Erivedge drug shows promise against advanced basal cell carcinoma

Erivedge drug shows promise against advanced basal cell carcinoma

Adjuvant chemoradiotherapy boosts esophageal cancer survival

Adjuvant chemoradiotherapy boosts esophageal cancer survival

bioTheranostics’ CancerTYPE ID molecular test improves overall survival for patients with CUP

bioTheranostics’ CancerTYPE ID molecular test improves overall survival for patients with CUP

VGXI, OncoSec partner to produce interleukin-12 plasmid DNA

VGXI, OncoSec partner to produce interleukin-12 plasmid DNA

Lilly announces final results from ALIMTA Phase III study on NSCLC

Lilly announces final results from ALIMTA Phase III study on NSCLC

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.